NCT07158515 The Heart Health After Cardiac Treatment Study
| NCT ID | NCT07158515 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Cardiac Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-28 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-11-28 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
Eligibility Criteria
Inclusion Criteria: 1. Age 18+ 2. Referred for cardiac rehabilitation for a covered indication: 1. Acute myocardial infarction 2. Percutaneous coronary intervention 3. Coronary artery bypass surgery 4. Heart valve repair or replacement 5. Heart transplant 6. Chronic stable angina 7. Chronic systolic heart failure (EF \<=35%) 3. Able to communicate in English, Spanish, or Cantonese 4. Able to consent for self Exclusion Criteria: 1. Currently enrolled in hospice. 2. Provider says patient may not be approached for participation in this study.
Contact & Investigator
Alexis Beatty, MD, MAS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07158515 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07158515 currently recruiting?
Yes, NCT07158515 is actively recruiting participants. Contact the research team at heartact@ucsf.edu for enrollment information.
Where is the NCT07158515 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07158515 clinical trial?
NCT07158515 is sponsored by University of California, San Francisco. The principal investigator is Alexis Beatty, MD, MAS at University of California, San Francisco. The trial plans to enroll 100 participants.